Todd Daviau, Ph.D.

President and CEO

Chief Executive Officer Todd Daviau, an accomplished scientific leader, brings 25+ years of pharmaceutical experience and knowledge to CoreRx, as well as being one of principal founders.

Prior to founding CoreRx, he served as Vice President of the Analytical and Pre-Formulation Laboratory for MDS Pharma Services in Tampa, FL. In this role, he directed the analytical group of over 20 scientists responsible for all the analytical, stability, and pre-formulation activities in support of over 75 stability, formulation and/or manufacturing projects.

Dr. Daviau was also a strategic analytical team member with Guilford Pharmaceuticals, and involved in a number of NDA programs, including the development of Gliadel®.

Todd is acknowledged as a creative leader focused on advancing projects with experience in multiple therapeutic areas. He is an expert in optimizing the drug discovery process through optimal resource allocation, process improvements and using scientific acumen to resolve complex project related issues. Todd brings a breadth of pharmaceutical experience, from drug discovery through research and development, analytical (R&D and QC.) and management experience in top-tier multinational pharmaceutical organizations. He is recognized as global, strategic thinker, with demonstrated ability to deliver pre-clinical and clinical candidates, within stringent timelines.

Dr. Daviau is also the founder and former Chairman of the Board of Magellan Bioscience Group, an innovative discovery company focused on identifying lead candidates derived from microorganisms for the development of new chemical entities.

Dr. Daviau holds a bachelor's degree in Marine Biology and Chemistry and a PhD in Natural Product Chemistry.